The results showed that high FCHSD1 expression was associated with shorter overall survival (OS) in cancer patients such as KIRC (p=0.001) and LGG (p<0.001), while increased FCHSD1 expression in BLCA (p=0.002) patients indicated prolonged OS (Figures 7F–H). This evidence concerns the gene FCHSD1 and cancer.